Why It Could Soon Be Time To Take Profits In This Highflying Biotech StockInvestors Business Daily • 11/08/19
This Biotech Stock Hurdled A Genetic Barrier — And Flirted With A BreakoutInvestors Business Daily • 10/18/19
Why This Newly Profitable Biotech Stock Is Flirting With A BreakoutInvestors Business Daily • 08/29/19
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/06/19
Why Arrowhead's Promising Gene Silencing Technology Makes The Stock A Strong BuySeeking Alpha • 07/31/19
Highly Rated Biotech Downgraded After Breaking Out And Running 39%Investors Business Daily • 06/28/19
Arrowhead Looks To Get Rare Liver Disease Drug Approved With Use Of Accelerated ApprovalSeeking Alpha • 06/27/19
Massive Increase In Short Interest Could Be Setting Bears Up For A Fall In Arrowhead PharmaceuticalsSeeking Alpha • 06/17/19
Arrowhead Pharmaceuticals Inc.'s (ARWR) CEO Christopher Anzalone on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19